Zobrazeno 1 - 10
of 31
pro vyhledávání: '"Bridget N Kelly"'
Autor:
Heather R. Faulkner, Suzanne B. Coopey, Rachel Sisodia, Bridget N. Kelly, Lydia R. Maurer, Dan Ellis
Publikováno v:
JPRAS Open, Vol 31, Iss , Pp 22-28 (2022)
Summary: Background: Enhanced recovery after surgery (ERAS) protocols are effective at reducing inpatient opiate use. There is a paucity of studies on the effects of an ERAS protocol on outpatient opiate prescriptions. The aim of this study was to de
Externí odkaz:
https://doaj.org/article/cf19c770ba3a4032aa4d43967ffb5e94
Autor:
Alexandra J. Webster, Julia N. Shanno, Heidi S. Santa Cruz, Bridget N. Kelly, Meghan Garstka, Anthony Henriquez, Michelle C. Specht, Michele A. Gadd, Francys C. Verdial, Anvy Nguyen, Tawakalitu O. Oseni, Suzanne B. Coopey, Barbara L. Smith
Publikováno v:
Annals of Surgical Oncology. 30:3215-3222
Autor:
Bridget N. Kelly, Alexandra J. Webster, Leslie Lamb, Tara Spivey, Jenna E. Korotkin, Anthony Henriquez, Michele A. Gadd, Kevin S. Hughes, Constance R Lehman, Barbara L. Smith, Michelle C. Specht
Publikováno v:
Clinical Breast Cancer. 22:e700-e707
Magnetic seeds have emerged as an alternative to wires for localization of nonpalpable breast lesions. The purpose of this study was to evaluate the utility of magnetic seeds compared to wires for preoperative localization.A retrospective cohort anal
Autor:
Michelle C. Specht, Bridget N. Kelly, Eleanor Tomczyk, Olivia A. Ford, Alexandra J. Webster, Barbara L. Smith, Michelle A. Gadd, Amy S. Colwell, Eric C. Liao
Publikováno v:
Annals of Surgical Oncology. 29:5711-5719
Autor:
Kevin S. Hughes, Michelle C. Specht, Barbara L. Smith, Michele A. Gadd, Heather R. Faulkner, Suzanne B. Coopey, Bridget N. Kelly, Carson Brown, Amy S. Colwell, Jenna E. Korotkin, T. Salewa Oseni, Conor R. Lanahan
Publikováno v:
Annals of Surgical Oncology. 29:1033-1040
Nipple-sparing mastectomy (NSM) is an oncologically safe alternative to skin-sparing mastectomy (SSM). This study evaluated whether NSM patients were more satisfied than SSM patients in short- and long-term follow-up. Women who underwent NSM or SSM b
Autor:
Anvy Nguyen, Meghan Garstka, Tawakalitu O. Oseni, Barbara L. Smith, Bridget N. Kelly, Michelle C. Specht, Michele A. Gadd, Suzanne B. Coopey, Alexandra Webster, Kevin S. Hughes, Jasmine A. Khubchandani, Anthony Henriquez
Publikováno v:
Annals of Surgical Oncology. 28:5657-5662
Nipple-sparing mastectomy (NSM) is now routinely offered to BRCA mutation carriers for risk reduction. We assessed the rates of ipsilateral cancer events after prophylactic and therapeutic NSM in BRCA1 and BRCA2 mutation carriers. BRCA1 and BRCA2 mut
Autor:
Alexandra J, Webster, Julia N, Shanno, Heidi S, Santa Cruz, Bridget N, Kelly, Meghan, Garstka, Anthony, Henriquez, Michelle C, Specht, Michele A, Gadd, Francys C, Verdial, Anvy, Nguyen, Tawakalitu O, Oseni, Suzanne B, Coopey, Barbara L, Smith
Publikováno v:
Annals of surgical oncology.
Retention of the nipple-areola complex with nipple-sparing mastectomy (NSM) techniques provides a more natural cosmetic result than procedures that sacrifice the nipple. While the oncologic safety of NSM is established by several studies, there is li
Autor:
Alexandra J Webster, Bridget N Kelly, Caroline McGugin, Suzanne B Coopey, Barbara L Smith, Michele A Gadd, Michelle C Specht
Publikováno v:
Journal of the American College of Surgeons. 234(6)
Radiofrequency identification tag localization (TL) and magnetic seed localization (MSL) are alternatives to wire localization (WL) for excision of nonpalpable breast lesions. We sought to compare localization methods with respect to operative time,
Autor:
Alexandra J. Webster, Julia N. Shanno, Heidi S. Santa Cruz, Bridget N. Kelly, Meghan Garstka, Anthony Henriquez, Michelle C. Specht, Michele A. Gadd, Francys C. Verdial, Anvy Nguyen, Tawakalitu O. Oseni, Suzanne B. Coopey, Barbara L. Smith
Publikováno v:
Annals of Surgical Oncology. 30:3223-3223
Publikováno v:
The American Surgeon. :000313482311578
Introduction Over the last decade, a paradigm shift has been made in treating pancreatic cancer. Starting in 2011, several trials demonstrated a survival advantage for multiagent chemotherapy (MAC). However, the implication for survival at the popula